Southern Asia: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Southern Asia

The South Asian human and animal blood market reduced slightly to $X in 2023, remaining constant against the previous year. The total consumption indicated prominent growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption increased by X% against 2021 indices. The level of consumption peaked at $X in 2018; however, from 2019 to 2023, consumption remained at a lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Southern Asia

In value terms, human and animal blood production dropped to $X in 2023 estimated in export price. Overall, production saw a resilient expansion. The pace of growth appeared the most rapid in 2017 with an increase of X%. Over the period under review, production hit record highs at $X in 2018; however, from 2019 to 2023, production stood at a somewhat lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Southern Asia

After three years of growth, shipments abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons in 2023. Over the period under review, exports, however, posted a prominent expansion. The most prominent rate of growth was recorded in 2022 when exports increased by X%. As a result, the exports attained the peak of X tons, and then fell markedly in the following year.

In value terms, human and animal blood exports shrank notably to $X in 2023. Overall, exports, however, recorded prominent growth. The growth pace was the most rapid in 2022 when exports increased by X%. As a result, the exports reached the peak of $X, and then declined significantly in the following year.

Exports by Country

The shipments of the one major exporters of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, namely India, represented more than two-thirds of total export.

India was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports, with a CAGR of X% from 2012 to 2023. India (X p.p.) significantly strengthened its position in terms of the total exports, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) also remains the largest human and animal blood supplier in Southern Asia.

From 2012 to 2023, the average annual growth rate of value in India amounted to X%.

Export Prices by Country

In 2023, the export price in Southern Asia amounted to $X per ton, picking up by X% against the previous year. Export price indicated slight growth from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, human and animal blood export price decreased by X% against 2018 indices. The most prominent rate of growth was recorded in 2018 an increase of X%. As a result, the export price attained the peak level of $X per ton. From 2019 to 2023, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for India.

From 2012 to 2023, the rate of growth in terms of prices for India amounted to X% per year.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Southern Asia

After two years of growth, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons in 2023. Over the period under review, imports, however, continue to indicate a strong increase. The pace of growth appeared the most rapid in 2022 with an increase of X%. As a result, imports attained the peak of X tons, and then reduced notably in the following year.

In value terms, human and animal blood imports fell notably to $X in 2023. In general, imports, however, posted a resilient increase. The pace of growth appeared the most rapid in 2022 when imports increased by X% against the previous year. As a result, imports reached the peak of $X, and then reduced markedly in the following year.

Imports by Country

In 2023, India (X tons) was the main importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, constituting X% of total imports. Pakistan (X tons) ranks second in terms of the total imports with a X% share, followed by Bangladesh (X%) and Nepal (X%). Sri Lanka (X tons) held a relatively small share of total imports.

From 2012 to 2023, average annual rates of growth with regard to human and animal blood imports into India stood at X%. At the same time, Bangladesh (X%), Pakistan (X%), Nepal (X%) and Sri Lanka (X%) displayed positive paces of growth. Moreover, Bangladesh emerged as the fastest-growing importer imported in Southern Asia, with a CAGR of X% from 2012-2023. While the share of Bangladesh (X p.p.) and India (X p.p.) increased significantly in terms of the total imports from 2012-2023, the share of Sri Lanka (X p.p.), Nepal (X p.p.) and Pakistan (X p.p.) displayed negative dynamics.

In value terms, India ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Southern Asia, comprising X% of total imports. The second position in the ranking was taken by Pakistan ($X), with a X% share of total imports. It was followed by Sri Lanka, with a X% share.

In India, human and animal blood imports increased at an average annual rate of X% over the period from 2012-2023. The remaining importing countries recorded the following average annual rates of imports growth: Pakistan (X% per year) and Sri Lanka (X% per year).

Import Prices by Country

In 2023, the import price in Southern Asia amounted to $X per ton, declining by X% against the previous year. Overall, the import price showed a noticeable downturn. The growth pace was the most rapid in 2019 an increase of X%. The level of import peaked at $X per ton in 2013; however, from 2014 to 2023, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Sri Lanka ($X per ton), while Bangladesh ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Sri Lanka (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform